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Abstract: Mechanical cues are employed to promote stem cell differentiation and functional 
tissue formation in tissue engineering and regenerative medicine. We have developed a 
Magnetic Force Bioreactor (MFB) that delivers highly targeted local forces to cells at a 
pico-newton level, utilizing magnetic micro- and nano-particles to target cell surface 
receptors. In this study, we investigated the effects of magnetically targeting and actuating 
specific two mechanical-sensitive cell membrane receptors—platelet-derived growth factor 
receptor α (PDGFRα) and integrin ανβ3. It was found that a higher mineral-to-matrix ratio 
was obtained after three weeks of magneto-mechanical stimulation coupled with osteogenic 
medium culture by initially targeting PDGFRα compared with targeting integrin ανβ3 and 
non-treated controls. Moreover, different initiation sites caused a differentiated response 
profile when using a 2-day-lagged magneto-mechanical stimulation over culture periods of 7 
and 12 days). However, both resulted in statistically higher osteogenic marker genes 
expression compared with immediate magneto-mechanical stimulation. These results 
provide insights into important parameters for designing appropriate protocols for ex vivo 
induced bone formation via magneto-mechanical actuation.  
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1. Introduction  
Cell-based bone tissue engineering is one essential strategy to treat and repair bone defects resulting 
from disease or traumatic injury. Traditionally, auto- or allo- bone grafts have been used to repair 
damaged bone. However, this modality is limited by factors such as limited availability, donor site 
morbidity and host immune rejection. Cell-based bone tissue engineering exploits in vitro expanded 
progenitor or stem cells, biodegradable scaffolds and other stimulatory biochemical or mechanical 
factors to induce the appropriate differentiation of cells to create implants for a defect site [1–3]. The 
proliferation capacity and differentiation potential are among the critical considerations for the success 
of the strategy. Although embryonic stem (ES) cells have ignited interest recently in their potential for 
clinical applications, due to the difficulties in obtaining homogenous populations of differentiated cells, 
the risk of teratoma formation, and complex ethical issues, ES cells have not been widely adopted in the 
clinic to date in most countries. Human bone marrow-derived mesenchymal stem cells (hMSCs), on the 
other hand, while more limited in their differentiation potential, are able to form clinically relevant tissues. 
In addition, they are relatively widely available, somewhat immuno-inert, and have been widely used for 
clinical trials for a variety of diseases including bone tissue defects as a consequence.  
In addition, mechanical stimulation has been proposed for pre-conditioning of osteoblast and stem 
cell-seeded constructs, ultimately for the production of tissue engineered bone with enhanced 
differentiation, mineralization and mechanical properties [4]. As such, not only the quality of  
tissue-engineered products but also the time period necessary for the generation of ex vivo bone could 
potentially be improved using mechanical stimulation. Techniques applying compressive or tensile 
loading to mechanically precondition cell-seeded constructs in vitro prior to implantation have been 
developed [5]. However, these approaches rely heavily on the mechanical properties of the 
biodegradable scaffolds used. There is an unmet need in tissue engineering applications for the 
development of techniques that apply forces directly to cells or even to mechano-responsive receptors 
within individual cells, bypassing the need to deform the surrounding scaffold as a whole and thereby 
rendering moot the requirement for mechanically strong scaffolds [5].  
The Magnetic Force Bioreactor (MFB) technique is a novel method of applying mechanical forces, in 
the pico-newton (pN) and nano-newton (nN) range, directly to molecular components of cells mediated 
by functionalized micro- or nano-particles over varying incubation periods for different purposes 
(Figure 1). While there are many studies focusing on the biological effects of magnetic fields, conflicting 
results have been demonstrated [6,7]. The MFB technique used in this study, combining magnetic fields 
with magnetic nanoparticles (MNPs) targeting specific cell surface receptors to control specific cell 
signaling pathways, is based on magneto-mechanical transduction. In this case, MNPs are the local 
‘force generators’ transducing an applied magnetic field to elicit a conformational change in a membrane 
protein/receptor in order to activate a specific signaling pathway. Furthermore, the incorporation of 
MNPs expands the potential application field of magnetic tissue engineering techniques as MNPs 
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functionality can be tailored by controlling MNP properties such as size, surface chemistry and 
bio-functionalization [8–12]. As such, targeting and activating diversified signaling transduction 
pathways and ensuing cell lineage commitment or tissue formation may potentially be achieved.  
Figure 1. Schematic diagram (A) and proposed underlying mechanism (B) of Magnetic 
Force Bioreactor (MFB). 
 
In our previous investigations, as well as in results reported here, field only controls were 
incorporated into the experiment design. In all cases, no apparent biological effects have been observed 
solely by application of magnetic field on cells. Iron oxide MNPs have been used as magnetic resonance 
imaging (MRI) contrast agent in the clinic and for cell isolation in clinical trials, and their 
biocompatibility is well documented as several iron-oxide/polymer composites have been cleared for 
clinical use by the U.S. Food and Drug Administration (FDA). 
Previous work has shown that the MFB can be utilized to apply mechanical forces to control cells for 
cell and tissue engineering applications [13–16]. Though these preliminary studies show potential, 
several questions relate to potential oncogenic effects, thorough toxicology studies, integrity and 
durability of the MFB-generated tissue matrix, and effects of time and sequence on activation of 
multiple receptors. However, magneto-mechanical activation of cell signaling pathways still has great 
potential to allow the usage of a variety of non-load-bearing matrices/scaffolds and also is capable of 
augmenting the mechanical strength and reducing the in vitro preparation time of bone tissue engineered 
constructs. Magneto-mechanical activation of MNP-tagged specific mechanosensitive receptors, 
TREK-1 and integrin, can induce adult hMSCs to differentiate along the osteochondrogenic  
lineage [17]. This technology represents an intriguing modality for long-term bone tissue engineering 
study. However, the spatio-temporal relationship between biochemical signaling activation and 
mechanical cues to promote differentiation is not yet clear [18–21]. 
Platelet-derived growth factor (PDGF) and PDGF receptors (PDGFRs) are also implicated in 
osteogeneis and bone formation, although their influence remains controversial. It is generally accepted 
that PDGF is not the sole factor capable of inducing osteogenic differentiation of MSCs [22]. PDGF 
ligands and receptors are elevated during tissue remodelling in bone fractures. In vivo application of 
PDGF has been shown to enhance bone formation in some reports [23–25] but confer inhibitory effects in 
other cases [26]. Imatinib-induced blockade of PDGFR(β) showed suppressive effects on the osteogenic 
differentiation of MSCs [27]; whereas promoting effects on the differentiation of osteoblasts and bone 
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formation have been demonstrated in several reports [28–30]. In our previous study, short-term 
mechanical stimulation of PDGFRs via MFB induced myogenesis of hMSCs [14]. However, no study of 
direct mechanical stimulation of PDGFR combined with osteogenic biochemical factors has been 
reported so far.  
In this study, we aim to define and characterize the protocols and parameters which are required for 
controlling hMSCs differentiation in vitro for bone tissue engineering. We describe optimization studies 
demonstrating the effects of magnetic particle presence and force application on osteogenesis and 
mineralization. The effect of initial targeting and mechanical stimulation of mechanosensitive 
platelet-derived growth factor receptor α (PDGFRα) and integrin over a long period, combined with 
osteogenic supplements on the osteogenesis of hMSCs, is examined. The temporal effects of mechanical 
stimuli at different stages of the osteogenic differentiation of hMSCs to promote maximal response are 
also explored. It is hypothesized that magnetic particle based techniques represent a valuable tool for 
stimulating and remotely controlling the differentiation of stem cells to osteoblasts over prolonged 
periods of time, and have potential applications in tissue engineering and regenerative medicine.  
2. Results and Discussion 
2.1. Magneto-Mechanical Stimulation Coupled with Biochemical Factors Directs the Osteogenic 
Differentiation of hMSCs 
HMSCs were plated onto 6-well plates and cultured in growth medium to confluence. After 3 weeks of 
daily application of magneto-mechanical stimulation, no mineral deposits were observed in groups 
without osteogenic supplements, whilst regions containing thickened fibers and large mineral deposits 
were observed when osteogenic supplements were added. HMSCs treated with magneto-mechanical 
stimulation combined with biochemical factors form mineralized nodules, which stain positively for 
calcium and phosphorous as demonstrated using co-staining of Alizarin Red S and von Kossa (Figure 2). 
These stains may have been localized to regions of dystrophic mineralization.  
FTIR analyses were conducted in order to examine and compare the mineralized ECM of hMSCs 
(Figure 3) and rule out the possibility of dystrophic mineralization. FTIR spectra corresponding to the 3 
sample types are displayed in Figure 3 for the wavenumber range of 400–1600 cm−1. This region covers 
four important components, i.e., the ν4 PO43− region (500–650 cm−1), which reveals apatitic and 
non-apatitic HPO42− or PO43− environments, the ν1 and ν3 phosphate (910–1180 cm−1), and the ν2 
carbonate band region (approximately 900–910 cm−1). The mineral-to-matrix ratio, crystallinity, and 
collagen cross-link ratio (XLR) of different groups are summarized in Table 1. The spectra obtained 
from the samples were evaluated as being carbonated hydroxyapatite minerals with variable carbonate 
substitutions for phosphate. The sub-bands at 1125 and 1020 cm−1 are characteristic of an immature 
hydroxyapatite rich in acid phosphate and carbonate substituents. However, human bone has a  
mineral-to-matrix ratio of 4.7:1 [31], which was substantially higher than for the ECM produced by 
hMSCs receiving different treatments (3.6:1, PDGFR-MNP; 2.8:1, RGD-MNP; 2.5:1, non-treated cells) 
in the presence of osteogenic media supplements. For 3 weeks magneto-mechanical stimulated groups, 
the mineral-to-matrix ratio of PDGFRα treatment group was significantly upregulated compared with 
non-treatment group assessed by FTIR (Table 1).  
Int. J. Mol. Sci. 2013, 14 19280 
 
 
Osteogenic marker expression was analysed over 3 weeks of culture in either proliferation medium or 
osteogenic medium (Figure 4). It is observed that collagen type I (Col I) and Runx 2 were enhanced in 
experiment groups receiving MFB treatment via RGD- or PDGFRα antibody- conjugated MNPs 
cultured in proliferation medium, although detected changes were not statistically significant compared 
with the non-treated control group. Whereas in osteogenic medium cultured cells, magnetic conditioning 
via PDGFRα antibody- functionalized MNPs, RGD-functionalized MNPs and MNP without 
conjugation exhibited enhanced Col I and Runx2 expression, while RGD-conjugation caused significant 
changes compared with the non-treated group. It is worth noting that Figure 4A,B shows the relative 
mRNA expression in different samples, and the ΔCt values of three target genes are much smaller in 
samples cultured in osteogenic medium compared with those cultured in proliferation medium (data not 
shown). This indicates that the established osteogenic differentiation of hMSCs in osteogenic medium 
cultured groups, which is consistent with the aforementioned histology staining and FTIR spectra data. 
In addition, the observed high errors in the group treated by PDGFRα antibody-conjugated MNPS 
combined with MFB exposure may be caused by the low expression level of PDGFRα in hMSCs 
compared with integrin, which led to varied targeting efficiency across different samples when cultured 
in proliferation medium; whereas when cell were cultured in osteogenic medium, the variation of 
targeting efficiency possibly was masked by the biochemical cue-induced osteogenesis.  
Figure 2. Morphology of undifferentiated hMSCs (a); magnetic nanoparticle (MNP) 
targeting PDGFRα (b) and integrin ανβ3 (c) in hMSCs, and histology analyses of hMSCs 
after 21 days of osteogenic induction (b–d). (a) Light microscope image, scale bar = 200 μm; 
(b) Confocal image of dextran (green) and F-actin (red) staining showing PDGFRα antibody 
functionalized MNP targeting in hMSCs, scale bar = 100 μm; (c) Confocal image of dextran 
(green) and nucleus (red) staining showing RGD peptide functionalized MNP targeting in 
hMSCs; (d) Alkaline phosphatase and von Kossa staining; (e) Alizarin red s staining;  
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Figure 3. FTIR spectra obtained before (A) and after (B) thermal gravimetric analysis of 
mechanical stimulated hMSCs (PDGFRα and RGD treatment) and non-treated hMSCs 
(Cell) following 3 weeks of culture. In both the PDGFRα treatment (denoted PGFRA in the 
plot) and RGD treatment (denoted RGD in the plot) groups, hMSCs were incubated with the 
appropriate antibody-conjugated MNPs and exposed to the MFB for 1 h per day for  
3 weeks. The MFB exposure frequency was set as 1 Hz. Medium was changed every other 
day. The mineral-to-matrix ratio was obtained by integrating the area under the curve 
between 900 and 1200 cm−1 (ν1, ν3 PO4 band) and dividing by the area under the curve 
between 1585 and 1725 cm−1 (amide I band) [32].  
 
Table 1. The results of FTIR spectroscopy analyses, giving a comparison of the 
mineralization in magnetically stimulated [platelet-derived growth factor receptor α 
(PDGFRα) and RGD treatment] and non-treated (Cell) human bone marrow-derived 
mesenchymal stem cells (hMSCs) following 3 weeks of culture (n = 3, mean ± SD). Mineral 
crystallinity is a parameter that corresponds to the crystallite size and perfection, and was 
calculated from the intensity ratios of sub-bands at 1030 (stoichiometric apatite) and  
1020 cm−1 (nonstoichiometric apatite) [33]. Collagen cross-link ratio (XLR) is a parameter 
reflecting the relative ratio of nonreducible and reducible collagen cross-links, expressed as 
the absorbance ratio at two specific wavenumbers (1660 and 1690 cm−1) [34]. 
Group Mineral/matrix ratio 1660/1690 ratio 1020/1030 ratio 
PDGFRα treatment 3.56 ± 0.52 2.48 ± 0.02 1.08 ± 0.01 
RGD treatment 2.82 ± 0.56 2.45 ± 0.08 0.07 ± 0.01 
Cell (nontreated) 2.53 ± 0.44 2.55 ± 0.04 1.06 ± 0.06 
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Figure 4. Osteogenic marker gene expression (relative fold change normalized to each 
control group) in hMSCs following 3 weeks of exposure to the MFB with cells cultured in 
(A) proliferation medium and (B) osteogenic medium (n = 3, mean ± SD, * p < 0.05). 
Experimental and control groups: PDGFRA: cells treated with PDGFRα antibody-conjugated 
MNPs; RGD: cells treated with RGD-conjugated MNPs; Cells: cells only (with field);  
NTC: non-treated control; MFB “+”: exposed to magnetic fields; MFB “−”: no field controls. 
 
2.2. PDGFR and Osteogenesis of hMSCs 
Osteoblasts arise from mesenchymal stem cells and the transition from stem cells to mature osteoblast 
is characterized by the formation of mineralized extracellular matrix and controlled by key osteogenic 
transcription factors, such as Runx2 and osterix [35]. The interplay of hormones, growth factors, and 
mechanical cues directs the osteogenic differentiation of hMSCs in vivo. The complexity of temporally 
and spatially orchestrating various factors for bone formation hinders the development of engineered 
functional bone. Bone morphological factors (BMPs) are one type of growth factors with wide 
application in research and clinical. PDGF also attracts emerging research efforts for its potential role in 
bone formation; however, effect of PDGF on osteogenesis of hMSCs is still in debate [36]. Inconsistent 
results may have resulted from differences in experimental conditions, especially the difference between 
in vitro and in vivo. However, evidence has shown that PDGF signaling is not competent to act as a sole 
factor in directing the commitment of hMSCs to the osteoblasts [22]. Results in this study confirmed that 
activation of PDGFRα alone is not sufficient to drive the differentiation of hMSCs down the osteoblast 
lineage in the absence of osteogenic supplements. 
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Figure 5. Schematic illustration of the proposed osteogenic differentiation of hMSCs 
induced by magneto-mechanical stimulation combined with biochemical signals. MNPs 
were functionalized with RGD peptide or PDGFRα antibody to target either integrin ανβ3  
or PDGFRα on cell surface membrane of hMSCs. When exposed to MFB, induced 
mechano-transduction coupled with biochemical signals directed the osteogenic 
differentiation and mineralization of hMSCs. 
 
In contrast, conditioning hMSCs using PDGFRα antibody-conjugated MNPs and the MFB enhanced 
the ECM mineralization after 3 weeks of culture in the presence of osteogenic supplements, and 
RGD-conjugated MNPs combined with MFB exposure augmented the mineral to matrix ratio to a lesser 
degree assessed by FTIR spectra (Figure 3). Cells treated with RGD-conjugated MNPs combined with 
MFB exposure showed enhanced expression of Col I, Runx2, ALKP and OCN, but significant changes 
were found only for Runx2. When considering that the expression levels of osteogenic markers are 
changed after magnetic conditioning, we hypothesize that: (1) Mechanical stimulation has a synergistic 
osteogenic function with the osteogenic medium; and (2) Following 3 weeks of mechanical stimulation, 
the MNPs may act as local force generators in the ECM and/or intracellular cytoplasm, possibly acting 
on intracellular force transducer components such as actin filaments. This might explain the increases in 
osteogenic marker expression in PDGFRα and integrin targeting combined with the MFB  
exposure group. A proposed schematic diagram outlining the mechanisms of magneto-mechanical 
stimulation-induced osteogenesis of hMSCs is illustrated in Figure 5. As reported by Thomas et al. [18], 
hMSCs responded to mechanical stimulation after they had advanced beyond a differentiation threshold, 
which may explain our observations in the proliferation medium cultured groups. Direct mechanical 
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stimulation from multipotent hMSCs might not guide cells along the osteoblast/osteocytes 
differentiation pathway, which requires proper temporal starting point to show a response.  
The actual scenarios and proportions of receptors occupied by MNPs remain to be elucidated. They 
may undergo similar processes to the trafficking and cycling of cell surface receptors upon cognate 
ligands engagement. Multiple studies have reported observations of receptor-mediated endocytosis of 
MNPs, which could provide anecdotal evidence for the fate of cell surface receptors occupied by MNPs. 
Diverse types of cell surface receptors and properties of MNPs are among the contribution factors for the 
scenarios ensuing the engagement of receptors by MNPs. It has been proposed that MNPs can be 
endocytosed together with targeted cell surface receptors or released from the receptors. It has been also 
been suggested that endocytosed receptors may maintain or is a necessary step to initiate their 
endogenous functionality following their endocytosis [37]. Moreover, considering the size of MNPs 
employed in our experiments, there may be a risk of masking endogenous ligand-induced receptor 
activation or reducing the targeting efficiency of MNPs. Taken together, we do not clearly understand 
the influence of the occupation of receptors by MNPs on the endogenous trafficking and recycling of 
receptors themselves. Further research is warranted in this area. 
2.3. Proposed Effect of Combinational Temporal Factors and Targeting Sites of Magneto-Mechanical 
Stimulation on Osteogenic Induction of hMSCs  
The influence of temporal and targeting sites of mechanical stimulation via PDGFRα- or  
RGD-conjugated MNPs on osteogenesis in hMSCs was investigated over a 7-day and 12-day period. For 
the temporal factors, the effects of preconditioning the cells by first culturing for 2 days in osteogenic 
induction medium were assessed. The groups of hMSCs that were and were not preconditioned with 
osteogenic medium are denoted T1 and T2 respectively. Firstly, as shown in Figure 6A, the levels of 
Runx2, Col I and OCN expression were upregulated in the group with 2 days of static osteogenic 
chemical induction (T1) compared to the group without static chemical preconditioning (T2) and 
non-treated (Control) group after 7 days of culture (Figure 6A). In contrast, the levels of alkaline 
phosphatase (ALKP) gene expression were lower in T1 with preconditioning compared to that in T2, the 
group without previous static osteogenic induction after 7 days of culture, and the control. However, the 
osteogenic marker gene expression profile was different after 12 days of culture compared to 7 days of 
culture: (i) RGD-conjugated MNPs combined with MFB exposure in T1 group induced Col I, ALKP and 
OCN expression compared with T2 groups, with Col I and OCN showing statistic significance; (ii) 
PDGFRα-conjugated MNPs combined with MFB appears to induce Runx2 and OCN expression in T1 
groups compared with T2 groups, although no statistic significance was detected (Figure 6B). 
Osteogenic markers expression in mRNA level in T1 groups had no significant difference compared 
with non-treated control group after 7 days and 12 days post-culture. These results demonstrate that cells 
at various stages of differentiation have different sensitivities to mechanical conditioning. In the case of 
the markers for early differentiation, expression was enhanced with preconditioning using well defined 
chemical induction followed by mechanical stimulation. For early differentiation markers such as 
Runx2, and key matrix markers such as Col I and OCN, expression was enhanced with preconditioning. 
ALKP analyses demonstrated a different pattern; no statistic significance of gene expression was 
detected in T1 groups compared with that in T2 groups and the control group over 7 days or 12 days of 
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culture. The asynchronous gene expression between ALKP and other osteogenic markers Col I, Runx2 
and OCN possibly reflected that a peak expression of ALKP has been reached in one earlier time points, 
which have been demonstrated by other researchers [38,39]. The results also provide the insight into the 
role of magnetic mechano-conditioning in defining stem cell differentiation pathways and optimizing the 
temporal induction towards terminal osteogenesis.  
We hypothesize that the MFB-based mechanical stimulation functions through the target-site specific 
and non-specific activation of downstream signaling pathways. For the target-site specific activation, the 
repertoire of cell surface molecules is critical for their interaction with antibody- or peptide- tagged 
MNPs, whereas for generic mechanical activation, the profile of extracellular matrix and intercellular 
cytoskeleton and other scaffold proteins decide the effect of mechanotranduction. It is conceivable  
that cells at different stages show differential responses to mechanical stimulation, including 
magneto-mechanical stimulation via MFB. Therefore, it is of great importance to explore the 
appropriately spatial and temporal factors for conditioning of hMSCs in order to augment the therapeutic 
effect of bone tissue engineering.  
Figure 6. Effect of the temporal factor and targeting site of magneto-mechanical stimulation 
on osteogenic differentiation of hMSCs. Osteogenic marker gene expression, assessed by 
qRT-PCR, after 7 days of culture (A) and 12 days of culture (B). The T1 groups were 
preconditioned for 2 days by culturing in osteogenic medium under static conditions, 
followed by 5 days (A) or 10 days (B) of magnetic conditioning; The T2 groups were not 
preconditioned and instead underwent 7 days (A) or 12 days (B) of magnetic conditioning 
synchronized with osteogenic medium induction.  
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Figure 6. Cont. 
 
In this study, a short term (7 days) in vitro mechanical stimulation mediated by PDGFRα  
antibody-conjugated MNPs with 2-day pre-static culture in the presence of osteogenic supplements 
showed a better osteogenic induction effect vs. without 2-days pre-static culture, mediated by  
RGD-conjugated MNPs and the control. The difference in gene response of the hMSCs cells with no 
conditioning (without osteogenic medium induction) and 2-day conditioning can be attributed to 
osteogenic differentiation of hMSCs. The subsequent positive response to mechanical stimulation after 
pre-differentiation may be ascribed to an increase in cell surface receptors such as mechanosensitive 
integrins or the presence of ECM molecules to facilitate the physical connections between the 
mechanical stimuli and the cell [40]. ECM is important in the mechanotransduction process as it is 
crucial to interpret forces from the surrounding environment and to transmit these forces to the cell 
surface receptors (integrins) and then to the cytoskeleton (scaffolding proteins) [41,42]. The change in 
the mechanoresponsive behaviour of the hMSCs following pre-conditioning with osteogenic 
supplements can lead to diversified gene responses, which are dependent on the stage of differentiation 
of the cells or scenarioin force propagation through the ECM. These results show the role of magnetic 
mechano-conditioning in defining stem cell differentiation pathways and optimizing the temporal 
induction towards terminal osteogenesis utilizing combinations of chemical and mechanical 
conditioning. In addition these data provide useful insight into the modality of preconditioning hMSCs 
before transplantation.  
3. Experimental Section  
3.1. Cell Culture 
Human bone marrow aspirates were purchased from Lonza (Slough, UK) and hMSCs were selected 
using the following plastic-adherent culture method. 0.5 mL of human bone marrow aspirate was added 
into T75 flask (Corning, Ewloe, UK) coated with 5 ng/mL fibronectin (Sigma, Dorset, UK) with  
10 mL of proliferation medium [DMEM supplemented with 5% FBS, 0.5% antibiotics and 200 mM  
Int. J. Mol. Sci. 2013, 14 19287 
 
 
L-glutamine (all purchased from Lonza, Slough, UK)]. After 1 week of culture at 37 °C, half volume of 
medium was replaced with fresh medium and further cultured for another week. Several colonies were 
formed in each T75 flask and adherent cells were trypsinized for further expansion or were directly used 
in experiments. The osteogenesis of hMSCs was performed using the following methods. HMSCs were 
seeded in 6- or 24-well plates at the density of 10,000 cells/cm2 and allowed to adhere and proliferate 
overnight. The culture medium was replaced with osteogenic medium [α-MEM (Invitrogen) 
supplemented with 10% FBS (Lonza), 100 nM dexamethasone (Sigma), 50 μg/mL ascorbic acid and  
10 mM β-glycerophosphate (BGP, Sigma)] on the next day. This medium was then changed every two 
days. Formation of mineralized nodules was determined on 6 or 24-well plates by alizarin red s 
histochemical staining [43]. 
3.2. Magnetic Particle Conjugation 
Anti-human PDGFRα antibody (R & D Systems, Abingdon, UK) was conjugated to the surface of 
250 nm superparamagnetic nanoparticles (Micromod, Rostock, Germany) after these particles had been 
functionalized with the Fc-specific secondary antibody (Sigma-Aldrich) according to the manufacturer’s 
protocol using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDAC) and 
N-hydroxysuccinimide (NHS) with the ratio of 20 μg of antibody per mg of MNP. For Arg-Gly-Asp 
(RGD, Sigma) conjugation, 80 μg of RGD was used for per mg of MNP (Micromode, 250 nm) following 
the similar protocol. The size and zeta potential of the MNPs with/without antibody conjugation was 
examined by A ZetaSizer (Malvern, Worcestershire, UK) at 25 °C, when dispersed in phosphate 
buffered saline (PBS) or in deionized H2O (dH2O).  
3.3. Visualization of MNP Targeting Cell Membrane 
For visualizing 250 nm particles targeting, cells were harvested using 4% paraformaldehyde after 
incubation with functionalized MNPs and removing unbound particles. Subsequently, cells were 
blocked for 30 min using 3% BSA. Then cells were incubated with anti-dextran antibody (STEMCELL 
Technologies, Sirocco, France) for 1 h at room temperature (RT) followed by FITC-conjugated secondary 
antibody (Santa Cruz, Heidelberg, Germany) for 1 h at RT. Subsequently cells were incubated either 
with Phalloidin-Atto 565 or with propidium iodide (PI) for 45 min at RT. MNPs targeting the cell 
membrane was assessed under confocal microscopy (Olympus, Southend-on-sea, UK).  
3.4. Application of MFB Technique in Osteogenesis of hMSC 
The MFB system (MICA Biosystems, Stoke-on-trent, UK) consists of horizontal arrays of NdFeB 
magnets, onto which cell culture plates can be situated (Figure 1). The frequency and amplitude of the 
oscillations of the array are controlled via a computerized stepper motor system. The field strength 
produced by the magnetic arrays of MFB in the vicinity of the cells is in the region of 60–120 mT with a 
field gradient of 3.3–11.0 Tm−1 [15]. In order to test the effects of mechanoreceptor stimulation via 
magnetic MFB exposure on hMSC mineralization, cells were incubated with antibody-conjugated 
MNPs for 1.5 h (25 μg particle suspension per well) after exposure to serum-free medium for 2 h. After 
washing with PBS twice to remove unbound MNPs, the MFB was used to apply translational force to the 
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receptor- bound MNPs. All samples receiving MFB exposure treatment followed the same protocol 
unless specified. The cells were cultured with or without magneto-mechanical stimulation over indicated 
periods after which differentiation and mineralization was assessed using histology staining and FTIR, 
and mRNA expression was characterized using qRT-PCR.  
3.5. Investigation of Temporal Effects of MFB on Osteogenesis of hMSCs 
HMSCs were seeded onto 6-well plates and cultured overnight in proliferation medium. This was 
replaced with fresh osteogenic medium on the next day and cells were assigned into 2 groups—T1 and 
T2. The T1 group was pre-treated with osteogenic medium for 2 days, before exposing the cells to  
5 days of magnetic conditioning using MFB for 1 h per day, targeting the mechanoresponsive receptor 
PDGFRα or integrin ανβ3. The T2 group was treated with magnetic conditioning directly after removing 
proliferation medium using the MFB at 1 h per day targeting either PDGFRα or integrin ανβ3 for 7 days. 
Two groups of cells were then harvested and the relative mRNA expression levels of Runx2, Col I, 
ALKP and OCN were measured by qRT-PCR.  
3.6. qRT-PCR 
Total mRNA was extracted by using TRI Reagent (Sigma, Dorset, UK) according to the 
manufacturer’s instructions. The quantity and quality of mRNA samples were checked using a 
NANODROP 2000 (Thermo, Wilmington, DE, USA). 1 μg of each mRNA sample was then reverse 
transcribed into cDNA using a QuantiTect Reverse Transcription Kit (Qiagen, Manchester, UK). 
Relative quantification by PCR was performed using Applied Biosystems reagents in 25 μL reaction 
systems containing 50 ng cDNA, 12.5 μL of 2× SYBR® PCR Master Mix, 1 μL of Primer (Qiagen, 
Manchester, UK) and a STRATGENE Mx3005P QPCR system (Agilent, Wokingham, UK). The cycle 
conditions were set according to the manufacturer’s protocol. The ΔΔCt methodology was used to 
analyse gene expression and GAPDH was employed as the housekeeping gene. All results were 
normalized to the non-treated control group respectively. 
3.7. Histology 
3.7.1. Alkaline Phosphatase and Von Kossa Double Staining  
Cells were fixed with 4% paraformaldehyde for 1–2 min and then rinsed with TBST buffer [20 mM 
Tris-HCl (pH 7.4), 0.15 M NaCl, and 0.05% Tween-20] briefly to remove paraformaldehyde. The  
500 µL of dye containing Fast Red Violet and Naphthol AS-BI Phosphate solution and deionized H2O 
(dH2O) in a ratio of 2:1:1 was added to each well and incubated at RT for 15 min in dark. Once ready, 
samples were thoroughly rinsed 4 times with dH2O. Freshly prepared 2.5% silver nitrate solution was 
administrated into each sample and incubated for 30 min in dark. After rinsing 4 times with dH2O, 
samples were incubated in 5% sodium carbonate in 25% formaldehyde for 5 min. Samples were rinsed 3 
times with dH2O and ready for examination under light microscopy (Leica, Milton Keynes, UK).  
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3.7.2. Calcium Staining  
At the end of experiments, cells were fixed with 4% paraformaldehyde for 15 min and rinsed  
3 times with PBS and 1 time with dH2O. 1 mL of freshly prepared 1% Alizarin Red S (Sigma, Dorset, 
UK) was administrated into each well and incubated at room temperature for 20 min. Stained samples 
were carefully rinsed 5 times with dH2O to remove physically trapped dye and examined under a  
Leica microscope.  
3.7.3. Collagen Staining  
Collagen staining was conducted using a picro-sirius red method [44]. In short, cells were fixed with 
10% neutralized formalin solution for 15 min and then washed 3 times with PBS. Nuclei were stained 
with haematoxylin (Sigma, Dorset, UK) for 8 min and then washed with running tap H2O.  
500 μL of picro-sirius red solution [0.1% (w/v)], prepared in saturated aqueous picric acid (1.3%, w/v, 
Sigma), was administrated into each well containing fixed samples and incubated for 1 h. Afterwards, 
samples were rinsed with acidified H2O (5 mL of glacial acetic acid in 1 litre of dH2O) twice and 
examined under a Leica light microscope.  
3.8. Thermal Gravimetric Analysis  
To examine the pure mineral phase of some specimens, thermal gravimetric analysis (TGA) of the 
bone nodules were performed using a TGA instrument (SDT 600, TA Instruments, New Castle, DE, 
USA), which burnt out the organic components and impurities from samples. The TGA was set to a 
heating rate of 20 °C min−1 with heat cycles from 20 to 600 °C. The obtained mineral phase of specimens 
undergoing different culture conditions were further analyzed by FTIR. 
3.9. FTIR 
Investigation of the mineral composition of generated nodules was performed by using FTIR 
spectroscopy (Bruker Alpha P, Coventry, UK) equipped with a single reflection diamond attenuated 
total reflectance (ATR) sampling module. At the end of culture, samples were harvested and dried at  
40 °C for 48 h. The FTIR spectra were obtained by recording scans between 4000 and 400 cm−1 with a 
resolution of 4 cm−1 with the FTIR spectrometer. Plots were baseline corrected and analyzed over the 
range of 500 to 1725 cm−1. After initial FTIR analysis, some samples were processed by TGA as 
described previously. The ashes that remained after the TGA procedure were collected from TGA 
sample holders and analyzed again by FTIR spectroscopy. Three spectroscopic parameters were 
calculated: mineral-to-matrix ratio, crystallinity, and collagen XLR.  
3.10. Statistical Analysis 
Data are presented as the mean ± standard error of the mean (SEM). Differences between groups were 
examined for statistical significance with one-way analysis of variance (ANOVA) using the Tukey least 
significance test for post-hoc comparisons. A minimal probability value of less than 5% was considered 
as statistically significant difference.  
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4. Conclusions  
In this study, we have demonstrated that the osteogenesis of hMSCs is significantly affected by 
mechanical stimulation via magnetic tagging. By initially targeting the cell membrane receptor 
PDGFRα, we have demonstrated that a significantly higher mineral:matrix ratio was present in the cells 
after 3 weeks of magneto-mechanical stimulation combined with osteogenic medium culture. Moreover, 
we have revealed the temporal effects of mechanical stimulation associated with the kinetics of 
ostegenesis and mineralization. Both over a short term (7 days) and the medium term (12 days) of culture, 
osteogenic marker genes were expressed at higher levels in response to the 2 day-lag prior to mechanical 
stimulation compared with immediate mechanical stimulation, but with a different response profile. 
Over a 7-day culture, cells showed a strong response to PDGFRα-conjugated MNP treatment; whereas 
in the medium stage, cells showed a strong response to RGD-conjugated MNP treatment. Taken 
together, this study has explored effect of the temporal factor and targeting site, which are crucial to 
MFB technique applications in tissue engineering and has enriched the knowledge of mechanical 
stimulation for bone construct engineering.  
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